Loading
CA
CAN Stock: price and insider trades · Australia
CAN: what insiders have been doing
Every trade that managers of CAN disclose to ASX is tracked on this page. The company sits in the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of CAN has been absent for the past year.
Compared with its exchange (2,530 companies, median 3 filings), a count of 2 filings is below the norm.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2024FY ended June 2024 · cache
A$0.00
Analyst consensus
Income statement
RevenueA$15.4M
Gross profitA$15.4M100% margin
EBITDA-A$33.4M-217% margin
Net income-A$51.2M210.4% margin
Valuation
PER (trailing)0.2x
P/Book0.2x
Beta0.11
Balance sheet & cash
Market capA$6.6M
Total debtA$72.5M
Free Cash Flow-A$17.7M
Debt / Equity56%
Profitability & ownership
ROE154.5%
ROA-10.4%
% insiders22.0%
% institutions3.6%
Last declaration on 29 June 2026
Declarations2 total
ShareASXASX:2924-03105111-3A696162
ShareASXASX:2924-03088608-3A693033
2 of 2 declarations
About CAN
CAN is a company operating in the healthcare and pharmaceutical sector. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
